The role of ursodeoxycholic acid in the treatment of chemotherapy induced hepatotoxicity in the maintenance treatment of children with acute leukemia
Introduction: Chemotherapeutic agents used in the treatment of leukemia patients may cause toxic effects in the liver where they are metabolized. Ursodeoxycholic acid (UDCA) is used because of its hepatoprotective effect in the treatment of drug-induced liver toxicity. This study investigated the ef...
Saved in:
Main Authors: | Sibel Tekgündüz (Author), Duygu Yıldırgan (Author), Hüseyin Avni Solgun (Author), Cengiz Bayram (Author), Ali Ayçiçek (Author), Özlem Terzi (Author) |
---|---|
Format: | Book |
Published: |
SERNEV,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Switching from Deferasirox Dispersible Tablets to Deferasirox Film-Coated Tablets: Is There an Effect on Ferritin Levels in Children and Adolescents with Transfusion-Dependent Anemia?
by: Esra Arslantaş, et al.
Published: (2024) -
Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
by: Chao Li, et al.
Published: (2020) -
Use of Ursodeoxycholic Acid for the Treatment of Biliary Dysfunction in Children
by: T.V. Yaroshevskaya, et al.
Published: (2013) -
Optimizing treatment of atopic dermatitis in infants using ursodeoxycholic acid
by: O.G. Shadrin, et al.
Published: (2017) -
Optimizing the Treatment of Atopic Dermatitis in Infants Using Ursodeoxycholic Acid
by: O.H. Shadrin, et al.
Published: (2016)